Health TrialsbyHealthPanel

The Pericapsular Nerve Block in Total Hip Arthroplasty

ConditionsHip OsteoarthritisHip Arthropathy
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorLifeBridge Health

About this trial

In order to continue progressing towards outpatient total hip arthroplasty (THA), methods to adequately manage postoperative pain is of paramount importance. The purpose of this study is to quantify the effectiveness of the pericapsular nerve block in total hip arthroplasty in comparison to the fascia iliaca nerve block.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Provision of signed and dated informed consent form

Stated willingness to comply with all study procedures and availability for the duration of the study

Planned primary total hip arthroplasty with anterior (Smith-Peterson) approach

ASA score of 1 to 3

Disqualifiers

Current or previous diagnosis of "chronic pain"

Opioid tolerant at time of screening (for a week or longer, at least 60 mg of morphine daily, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid.)

Diagnosis of ankylosing spondylitis

Allergy to any potential medications utilized in any of the two groups

Trial design

Design model

Parallel

Treatments tested in this trial

  • Pericapsular Nerve Block

    Drug

    Per Standard Institutional Practice

  • Fascia Iliaca Nerve Block

    Drug

    Per Standard Institutional Practice

Treatment groups

78 Participants
are divided into 2 treatment groups
Group A: Pericapsular Nerve Block GroupActive comparator 1 intervention
Group B: Fascia Iliaca Nerve Block GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Visual Analog Pain Scale (VAS) Score

Score recorded by drawing a vertical line on a 100 mm horizontal line between "No Pain" (0 mm) and "Worst Pain" (100 mm)

Time frame
Every 4 hours from end of surgery to 48 hours post surgery or discharge
2

Postoperative Opioid Consumption in mg

Total opioid consumption will be recorded during postoperative period and at 1 month follow-up visit

Time frame
Surgery to 1 month post surgery

Secondary outcomes

1

Time to first opioid medication

Time frame
End of surgery 48 hours post-operation or discharge
2

Time to first ambulation

Time frame
End of surgery to 48 hours post-operation or discharge
3

Distance upon first ambulation

Time frame
48 hours postoperative or discharge
4

Incidence of weakness and falls

Time frame
End of surgery to 48 hours post-operation or discharge

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

LifeBridge Health

Lead sponsor

Rubin Institute for Advanced Orthopedics

Collaborator

Source ClinicalTrials.gov
Apply now